EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Evaluation of Organoid‐Derived Exosomal microRNA as Liquid Biopsy for Colorectal Cancer: A Multicenter Cross‐Sectional Study

Atsuhiro Sasaki, Masatake Kuroha iD, Masaki Tosa, Seiichi Takahashi, Shinya Oomori, Eiki Nomura, Tatsuya Kikuchi, Motoyuki Onodera, Yuichiro Sato, Teruko Miyazawa, Hirofumi Chiba, Naonobu Yokoyama und 16 weitere

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70270 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Atsuhiro Sasaki und 27 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Organoids, Exosomes, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomal microRNAs (miRNAs) are candidates for liquid biopsies. Organoid culture systems enable long‐term expansion of the colon epithelium. This study evaluated exosomal miRNAs from colorectal cancer organoids for liquid biopsy. Organoids were established from normal colon and colorectal cancer tissues. Exosomes were isolated from conditioned media. miRNAs were extracted from exosomes and compared using microarray analysis. Exosomal miRNAs expression levels in the sera of healthy patients and patients with colorectal cancer were compared at a single institution. The multicenter study was validated using miRNAs upregulated in the serum of colorectal cancer patients, along with exosomal miRNAs reported to be upregulated in colorectal adenoma organoids and sera. A total of 44 exosomal miRNAs were commonly expressed in both normal colorectal epithelial cells and colorectal cancer organoids, whereas 59 were exclusively expressed in colorectal cancer organoids. In a single‐center cohort study, two exosomal miRNAs (miR‐4284 and miR‐5100) were upregulated in the serum of colorectal cancer patients. In a multicenter study, four exosomal miRNAs (miR‐4284, miR‐5100, miR‐1246, and miR‐1290) were upregulated in the serum of patients with colorectal cancer. The combination of these four exosomal miRNAs had comparable diagnostic performance to carcinoembryonic antigen, with an area under the curve of 0.75 (95% confidence interval: 0.65–0.83) versus 0.79 (95% confidence interval: 0.70–0.87). Combining the four miRNAs with carcinoembryonic antigen improved diagnostic accuracy, with an area under the curve of 0.82 (95% confidence interval: 0.74–0.89). Exosomal miRNAs derived from colorectal cancer organoids can serve as diagnostic biomarkers for colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsOrganoidsExosomesMicroRNAsBiomarkers, TumorHumansLiquid BiopsyMaleFemaleMiddle AgedCross-Sectional StudiesAgedGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

carcinoembryonic antigenmiR‐1246miR‐1290miR‐4284miR‐5100

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Gastroenterology, Iwaki City Medical Center, Iwaki, Japan.
  • Department of Gastroenterology, Japanese Red Cross Sendai Hospital, Sendai, Japan.
  • Department of Gastroenterology, Sendai City Hospital, Sendai, Japan.
  • Department of Gastroenterology, Osaki Citizen Hospital, Osaki, Japan.
  • Department of Gastroenterology, Japan Community Healthcare Organization, Sendai South Hospital, Sendai, Japan.

ORCID-Profile: Masatake Kuroha, Yoichi Kakuta

Zitieren

APA

Sasaki, A., Kuroha, M., Tosa, M., Takahashi, S., Oomori, S., Nomura, E., Kikuchi, T., Onodera, M., Sato, Y., Miyazawa, T., Chiba, H., Yokoyama, N., Kusaka, J., Okamoto, D., Handa, T., Sugimura, M., Iwabuchi, M., Hiramoto, K., Shirota, H., …, & Masamune, A. (2025). Evaluation of Organoid‐Derived Exosomal microRNA as Liquid Biopsy for Colorectal Cancer: A Multicenter Cross‐Sectional Study. Clinical and Translational Science. https://doi.org/10.1111/cts.70270

Vancouver

Sasaki A, Kuroha M, Tosa M, Takahashi S, Oomori S, Nomura E, et al. Evaluation of Organoid‐Derived Exosomal microRNA as Liquid Biopsy for Colorectal Cancer: A Multicenter Cross‐Sectional Study. Clinical and Translational Science. 2025. doi:10.1111/cts.70270

BibTeX
@article{Sasaki2025,
  author = {Sasaki, Atsuhiro and Kuroha, Masatake and Tosa, Masaki and Takahashi, Seiichi and Oomori, Shinya and Nomura, Eiki and Kikuchi, Tatsuya and Onodera, Motoyuki and Sato, Yuichiro and Miyazawa, Teruko and Chiba, Hirofumi and Yokoyama, Naonobu and Kusaka, Jun and Okamoto, Daisuke and Handa, Tomoyuki and Sugimura, Mikako and Iwabuchi, Masahiro and Hiramoto, Keiichiro and Shirota, Hidekazu and Iwaki, Hideya and Nagai, Hiroshi and Shimoyama, Yusuke and Naito, Takeo and Moroi, Rintaro and Shiga, Hisashi and Kakuta, Yoichi and Kinouchi, Yoshitaka and Masamune, Atsushi},
  title = {Evaluation of Organoid‐Derived Exosomal microRNA as Liquid Biopsy for Colorectal Cancer: A Multicenter Cross‐Sectional Study},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70270}
}
Kostenlos starten →